Medicare Enrolled
Dr. Humberto Caldera, M.D.
Internal Medicine · Lake Worth, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Caldera from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Caldera? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Caldera
Dr. Humberto Caldera is an internal medicine in Lake Worth, FL, with 19 years in practice. Based on federal Medicare data, Dr. Caldera performed 55,678 Medicare services across 2,698 unique beneficiaries.
Between the years covered by Open Payments, Dr. Caldera received a total of $77,427 from 105 pharmaceutical and/or device companies across 1338 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Caldera is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 1% volume in FL$ $77,427 industry payments
Medicare Practice Summary
Medicare Utilization ↗55,678
Medicare services
Top 1% in FL for internal medicine
2,698
Unique beneficiaries
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,930 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) | 20,250 | $1 | $4 |
| Darbepoetin injection (Aranesp) for anemia | 12,400 | $2 | $9 |
| Injection, heparin sodium, (heparin lock flush), per 10 units | 3,700 | $0 | $0 |
| Epoetin alfa injection (Procrit) for anemia | 3,580 | $6 | $20 |
| Anti-nausea injection (ondansetron/Zofran) | 2,704 | $0 | $4 |
| Dexamethasone injection (steroid) | 1,860 | $0 | $2 |
| Complete blood count (CBC) with differential | 1,397 | $7 | $24 |
| Iron infusion (Monoferric) | 1,200 | $16 | $56 |
| Blood draw (venipuncture) | 1,092 | $8 | $12 |
| Infusion, normal saline solution, 250 cc | 1,059 | $1 | $7 |
| Comprehensive metabolic blood panel | 872 | $10 | $38 |
| Office visit, established patient (30-39 min) | 754 | $94 | $150 |
| Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg | 612 | $106 | $484 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 465 | $22 | $175 |
| Drug injection, under skin or into muscle | 355 | $11 | $45 |
| Administration of chemotherapy into vein, 1 hour or less | 316 | $100 | $270 |
| Carcinoembryonic antigen (cea) protein level | 265 | $19 | $65 |
| Administration of chemotherapy into vein, each additional hour | 215 | $23 | $90 |
| Iron level test | 193 | $6 | $30 |
| Transferrin (iron binding protein) level | 193 | $12 | $40 |
| Ferritin level test (iron stores) | 191 | $13 | $47 |
| Administration of additional new drug or substance into vein, 1 hour or less | 187 | $52 | $170 |
| Hospital follow-up visit, high complexity | 166 | $98 | $150 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 155 | $16 | $65 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 135 | $56 | $125 |
| Initial hospital admission, high complexity | 130 | $142 | $280 |
| Injection, diphenhydramine hcl, up to 50 mg | 129 | $1 | $4 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 123 | $20 | $55 |
| Lactate dehydrogenase (enzyme) level | 122 | $6 | $15 |
| Office visit, established patient, complex (40-54 min) | 110 | $142 | $200 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 109 | $17 | $32 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 104 | $1 | $13 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 90 | $49 | $155 |
| Vitamin B-12 level test | 86 | $15 | $55 |
| Administration of additional new drug or substance into vein using push technique | 84 | $44 | $160 |
| Folic acid level test | 80 | $14 | $32 |
| Irrigation of implanted venous access drug delivery device | 69 | $19 | $100 |
| New patient office visit, complex (60-74 min) | 47 | $171 | $300 |
| Thyroid stimulating hormone (TSH) test | 42 | $16 | $32 |
| PSA test (prostate cancer screening) | 21 | $18 | $69 |
| Red blood count, manual test | 16 | $4 | $18 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
41.9% high complexity
46.7% medium
11.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$77,427
Total received (2018-2024)
Avg $11,061/year across 7 years
Top 1% in FL for internal medicine
105
Companies
1,338
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$43,349 (56.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$24,215 (31.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$9,863 (12.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$8,116
2023$4,459
2022$8,005
2021$6,451
2020$8,180
2019$15,958
2018$26,258
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Takeda Pharmaceuticals U.S.A., Inc.
$32,691
Incyte Corporation
$4,630
Teva Pharmaceuticals USA, Inc.
$3,655
PFIZER INC.
$3,568
AstraZeneca Pharmaceuticals LP
$3,071
Exelixis Inc.
$3,043
Seagen Inc.
$1,937
Pharmacosmos Therapeutics Inc.
$1,799
Janssen Biotech, Inc.
$1,551
E.R. Squibb & Sons, L.L.C.
$1,481
Puma Biotechnology, Inc.
$1,315
Bayer Healthcare Pharmaceuticals Inc.
$1,283
Celgene Corporation
$985
Sirtex Medical Inc
$968
Novartis Pharmaceuticals Corporation
$944
Amgen Inc.
$925
Astellas Pharma US Inc
$898
GENZYME CORPORATION
$877
Merck Sharp & Dohme LLC
$702
Lilly USA, LLC
$666
Genentech USA, Inc.
$657
Daiichi Sankyo Inc.
$567
Merck Sharp & Dohme Corporation
$548
Boehringer Ingelheim Pharmaceuticals, Inc.
$521
Tempus AI, Inc
$505
EMD Serono, Inc.
$445
Pharmacyclics LLC, An AbbVie Company
$398
Stemline Therapeutics Inc.
$349
Regeneron Healthcare Solutions, Inc.
$339
GlaxoSmithKline, LLC.
$318
Bayer HealthCare Pharmaceuticals Inc.
$306
Alexion Pharmaceuticals, Inc.
$288
PUMA BIOTECHNOLOGY, INC.
$275
Eisai Inc.
$264
JAZZ PHARMACEUTICALS INC.
$262
ABBVIE INC.
$199
BeiGene USA, Inc.
$197
Ipsen Biopharmaceuticals, Inc
$187
Seattle Genetics, Inc.
$185
G1 Therapeutics, Inc.
$136
Advanced Accelerator Applications
$125
Novocure Inc.
$125
AVEO Pharmaceuticals, Inc.
$125
Gilead Sciences, Inc.
$124
ARRAY BIOPHARMA INC
$118
Kyowa Kirin, Inc.
$105
Kite Pharma, Inc.
$101
Karyopharm Therapeutics Inc.
$101
Janssen Products, LP
$100
AbbVie Inc.
$96
Mirati Therapeutics, Inc.
$94
Adaptive Biotechnologies Corporation
$92
Janssen Pharmaceuticals, Inc
$89
Rigel Pharmaceuticals, Inc.
$87
Alnylam Pharmaceuticals Inc.
$82
AbbVie, Inc.
$78
ADC Therapeutics America, Inc.
$74
Helsinn Therapeutics (U.S.), Inc.
$73
Jazz Pharmaceuticals Inc.
$70
SOBI, INC
$69
SERVIER PHARMACEUTICALS LLC
$69
Spectrum Pharmaceuticals Inc.
$69
Dova Pharmaceuticals
$66
Octapharma USA, Inc.
$66
Deciphera Pharmaceuticals Inc.
$62
Blueprint Medicines Corporation
$60
Verastem, Inc.
$58
Pharmacyclics LLC, an AbbVie Company
$55
RECORDATI_RARE_DISEASES_INC.
$54
TAIHO ONCOLOGY, INC.
$53
TerSera Therapeutics LLC
$50
MEDIVATION FIELD SOLUTIONS LLC
$50
EISAI INC.
$50
AMAG Pharmaceuticals, Inc.
$42
Mylan Institutional Inc.
$40
Heron Therapeutics, Inc.
$38
Blue Earth Diagnostics Limited
$38
Organon LLC
$38
Foundation Medicine, Inc.
$37
Midatech Pharma US Inc
$36
MorphoSys, US Inc.
$32
Aurobindo Pharma USA, Inc.
$31
Apellis Pharmaceuticals, Inc.
$31
Intuitive Surgical, Inc.
$29
Array BioPharma Inc.
$27
Agios Pharmaceuticals, Inc.
$27
Legend Biotech USA Inc.
$26
Tolmar, Inc.
$25
SANOFI-AVENTIS U.S. LLC
$23
Acrotech Biopharma Inc.
$22
Boston Scientific Corporation
$21
PharmaEssentia USA Corporation
$20
Fortovia Therapeutics, Inc.
$20
Taiho Oncology, Inc.
$19
INSYS Therapeutics Inc
$19
Sobi, Inc
$18
Ethicon Inc.
$18
Clovis Oncology, Inc.
$18
Dendreon Pharmaceuticals LLC
$18
CSL Behring
$16
SUN PHARMACEUTICAL INDUSTRIES INC.
$16
ACCORD HEALTHCARE, INC.
$16
TOLMAR Pharmaceuticals, Inc.
$16
Myovant Sciences Inc.
$14
ImmunoGen, Inc.
$13
Top 3 companies account for 52.9% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AUGTYRO · AYVAKIT · Abraxane · Alecensa · Axumin · BAVENCIO · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Beleodaq · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CAMCEVI · CARVYKTI · CINVANTI · COSELA · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DOPTELET · Da Vinci Surgical System · Doptelet · ELIGARD · ELIQUIS · ELITEK · ELZONRIS · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · Elahere · Empaveli · Enhertu · Erleada · FASLODEX · FERAHEME · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Folotyn · GAVRETO · GAZYVA · GILOTRIF · GIVLAARI · Gelclair · Halaven · Herceptin · IBRANCE · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kcentra · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lutathera · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · Monarch Platform · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OCTAGAM · OJJAARA · ONPATTRO · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Ogivri · Onivyde · Optune · Orserdu · PADCEV · PANZYGA · PEMAZYRE · PIQRAY · PLUVICTO · POSLUMA · POTELIGEO · PROMACTA · PROVENGE · Padcev · Phesgo · Pomalyst · Prolia · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · RYZNEUTA · Revlimid · Rezlidhia · Rubraca · SANCUSO · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · SYLVANT · SYNDROS · Stivarga · TAGRISSO · TALVEY · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tecentriq · TheraSphere Y90 Glass Microspheres 10 GBq · Tibsovo · Trodelvy · Turalio · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · Vectibix · Venclexta · Vitrakvi · WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XT CDX · XTANDI · Xofigo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · ZYTIGA · Zevalin · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (56%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for internal medicine in FL.
Equivalent to $139 per 100 Medicare services performed
Geographic Context
Internal Medicines within 10 mi
998
Per 100K population
66.2
County median income
$81,115
Nearest hospital
HCA FLORIDA JFK HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Caldera is a mixed practice specialist, with above-average Medicare volume (top 1% in FL), and high industry engagement (speaking/promotional, top 1%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Caldera experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Caldera performed 20,250 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Caldera receive payments from pharmaceutical companies?
Yes. Dr. Caldera received a total of $77,427 from 105 companies across 1,338 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Caldera's costs compare to other internal medicines in Lake Worth?
Dr. Caldera's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Caldera) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicines in Lake Worth
Browse internal medicines in Lake Worth ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicines in FL
Internal Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicines in FL
Which FL internal medicines receive the most from drug and device companies.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc..
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
By company
Teva Pharmaceuticals USA, Inc. Payments to Doctors
See all physicians who received payments from Teva Pharmaceuticals USA, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology